Ortoreab - Company finances
|
EUR
|
2020
From: 2020-05-04
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 1,997 | 24,587 | 32,675 | 50,507 | 99,725 | 101,112 |
| Profit before tax | -692 | 3,316 | 88 | 5,280 | 222 | 1,232 |
| Net profit | -692 | 3,185 | 84 | 5,012 | 210 | 1,232 |
| Equity | -682 | 2,503 | 2,587 | 7,599 | 7,809 | 9,042 |
| Liabilities | - | - | 18,338 | 14,342 | 29,456 | 31,080 |
| Non-current assets | 800 | 16,842 | 20,418 | 18,996 | 29,133 | 30,212 |
| Current assets | 29 | 2,682 | 797 | 2,945 | 8,132 | 9,910 |
| Total assets | 829 | 19,524 | 21,215 | 21,941 | 37,265 | 40,122 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 1,895 | 6,379 | 2,455 |
| Social insurance contributions | - | - | - | 2,052 | 2,312 | 3,020 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +1131.2% | +32.9% | +54.6% | +97.4% | +1.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -83.5% | 16.3% | 0.4% | 22.8% | 0.6% | 3.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 127.2% | 3.2% | 66.0% | 2.7% | 13.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -34.7% | 13.0% | 0.3% | 9.9% | 0.2% | 1.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -34.7% | 13.5% | 0.3% | 10.5% | 0.2% | 1.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 7.1 | 1.9 | 3.8 | 3.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 24,587 | 15,684 | 9,936 | 10,685 | 11,896 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ortoreab - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-23 | 2026-08-07 | 0.51 |
| 2026-06-16 | 2026-06-17 | 630.05 |
| 2026-05-03 | 2026-05-11 | 0.41 |
| 2026-04-24 | 2026-04-29 | 0.41 |
| 2026-02-18 | 2026-02-23 | 230.35 |
| 2026-01-21 | 2026-02-11 | 0.24 |
| 2025-12-16 | 2025-12-16 | 454.81 |
| 2025-10-23 | 2025-11-04 | 0.25 |
| 2025-09-16 | 2025-09-16 | 489.96 |
| 2025-07-24 | 2025-08-17 | 0.33 |
| 2025-04-16 | 2025-04-16 | 603.79 |
Ortoreab - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-02 | 2026-03-13 | 0.02 |
| 2026-02-21 | 2026-02-21 | 27.0 |
| 2025-01-01 | 2025-01-13 | 0.95 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ortoreab, MB (code 305544770) is a Small partnership engaged in Medical specialists activities. In the latest financial year, 2025, revenue reached €101.1K, up 1.4% year on year and 100.2% above the 2023 level. Net profit increased to €1.2K from €210 in 2024, while the net margin stood at 1.2%, indicating only modest profitability. The company’s trajectory has been one of rapid sales expansion followed by a sharp compression in earnings: in 2023 it generated €50.5K of revenue and €5.0K of net profit, and in 2024 revenue almost doubled to €99.7K while profit fell to €210. At the end of 2025, total assets were €40.1K, financed by €9.0K of equity and €31.1K of liabilities. Long-term assets amounted to €30.2K and short-term assets to €9.9K. The equity ratio was 22.5%, debt-to-equity 3.44, and asset turnover 2.52x. Revenue per employee was €12.6K, while profit per employee was €154, showing limited earnings conversion despite higher turnover.